KYAH02-2016-078

N/A

Report date: 2025/10/28 16:37:41

Base Information

Drug NameKYAH02-2016-078
Drug Alias NameKYAH02-2016-078
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChina Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina Resources Sanjiu Medical & Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A